Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Children's Oncology Group
ClinicalTrials.gov Identifier:
NCT00107458
First received: April 5, 2005
Last updated: August 6, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2012
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
Publications: